Do novel biomarkers have utility in the diagnosis and prognosis of AKI?: CON

Do novel biomarkers have utility in the diagnosis and prognosis of AKI?: CON

Manuscript Type: Debates in Nephrology.

Leer Artículo Leer Artículo

AnteriorHyperlactatemia is a predictor of mortality in patients undergoing continuous renal replacement therapy for acute kidney injury.
Siguiente Do novel biomarkers have utility in the diagnosis and prognosis of acute kidney injury?: PRO

Noticias relacionadas

Desafíos y dilemas del reemplazo renal en el adulto mayor con enfermedad renal aguda. La dificultad en decir NO.

RED-IRA, Temas del Mes

Do novel biomarkers have utility in the diagnosis and prognosis of acute kidney injury?: PRO

Articulos, RED-IRA

Comentarios deshabilitados